Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
99pct
520d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Medical Marijuana Research Act This bill establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Read twice and referred to the Committee on the Judiciary.
Received in the Senate.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
Considered under suspension of the rules. (consideration: CR H7076-7083)
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 508.
Committee on the Judiciary discharged.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2471, Consolidated Appropriations Act, 2022, including provisions related to the Cyber Incident Reporting for Critical Infrastructure Act of 2022 H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6151, Highway Accident Fairness Act of 2021, including provisions related to third-part litigation funding disclosures H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 8152, American Data Privacy and Protection Act H.R. 9665, To amend the Water Infrastructure Finance and Innovation Act of 2014 to establish payment and performance security requirements for projects, and for other purposes S. 224, Promoting Digital Privacy Technologies Act S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning. General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity. General discussions related to the Driver's Privacy Protection Act. Discussions related to surety bonding requirements in the WIFIA program. Discussions regarding CISA RFI on Cyber Incident Reporting for Critical Infrastructure Act. Discussions regarding Treasury Departments Federal Insurance Office request for comment (RFC) on Potential Federal Insurance Response to Catastrophic Cyber Incidents.
Client expense: $440,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of
2022 · third_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2471, Consolidated Appropriations Act, 2022, including provisions related to the Cyber Incident Reporting for Critical Infrastructure Act of 2022 H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6151, Highway Accident Fairness Act of 2021, including provisions related to third-part litigation funding disclosures H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 8152, American Data Privacy and Protection Act S. 224, Promoting Digital Privacy Technologies Act S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning. General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity. General discussions related to the Driver's Privacy Protection Act. Discussions related to surety bonding requirements in the WIFIA program. Discussions regarding CISA RFI on Cyber Incident Reporting for Critical Infrastructure Act. Discussions regarding Treasury Departments Federal Insurance Office request for comment (RFC) on Potential Federal Insurance Response to Catastrophic Cyber Incidents.
2022 · second_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2471, Consolidated Appropriations Act, 2022, including provisions related to the Cyber Incident Reporting for Critical Infrastructure Act of 2022 H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6151, Highway Accident Fairness Act of 2021, including provisions related to third-part litigation funding disclosures H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 8152, American Data Privacy and Protection Act S. 224, Promoting Digital Privacy Technologies Act S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity General discussions related to the Driver's Privacy Protection Act
2022 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · second_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2471, Consolidated Appropriations Act, 2022, including provisions related to the Cyber Incident Reporting for Critical Infrastructure Act of 2022 H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6151, Highway Accident Fairness Act of 2021, including provisions related to third-part litigation funding disclosures H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 8152, American Data Privacy and Protection Act S. 224, Promoting Digital Privacy Technologies Act S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity General discussions related to the Driver's Privacy Protection Act
Committee on the Judiciary discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Markup by |
| September 9, 2020 |
| Judiciary Committee | House | Referred to | July 17, 2019 |
| Energy and Commerce Committee | House | Referred to | July 17, 2019 |
| July 17, 2019 |
| Republican |
| WA |
| Chris Stewart | Republican | UT |
| Debbie Dingell | Democratic | MI |
| Dina Titus | Democratic | NV |
| Earl L. "Buddy" Carter | Republican | GA |
| Eleanor Holmes Norton | Democratic | DC |
| Greg Walden | Republican | OR |
| H. Morgan Griffith | Republican | VA |
| J. Luis Correa | Democratic | CA |
| John R. Curtis | Republican | UT |
| Lisa Blunt Rochester | Democratic | DE |
| Lloyd Smucker | Republican | PA |
| Matt Gaetz | Republican | FL |
| Raúl M. Grijalva | Democratic | AZ |
| Rob Bishop | Republican | UT |
| Sean Casten | Democratic | IL |
| Vicky Hartzler | Republican | MO |
| Zoe Lofgren | Democratic | CA |
Client expense: $720,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of
Client expense: $470,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of
Client expense: $470,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of
2022 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · first_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2471, Consolidated Appropriations Act, 2022, including provisions related to the Cyber Incident Reporting for Critical Infrastructure Act of 2022 H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6151, Highway Accident Fairness Act of 2021, including provisions related to third-part litigation funding disclosures H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224, Promoting Digital Privacy Technologies Act. S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity General discussions related to the Driver's Privacy Protection Act
Client expense: $450,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of
2022 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE
2021 · fourth_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602, Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2687, To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138, The State and Local Cybersecurity Improvement Act H.R. 3223, CISA Cyber Exercise Act H.R. 3264, Domains Critical to Homeland Security Act H.R. 3797, (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 5823, Pandemic Risk Insurance Act of 2021 H.R. 6032, (114th CONGRESS), Data Breach Insurance Act H.R. 6359, (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049, (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224, Promoting Digital Privacy Technologies Act. S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program including a focus on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity General discussions related to the Driver's Privacy Protection Act
Client expense: $500,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Security Council (NSC), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2021 · third_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602 Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2687 To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138 The State and Local Cybersecurity Improvement Act H.R. 3223 CISA Cyber Exercise Act H.R. 3264 Domains Critical to Homeland Security Act H.R. 3797 (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 4350/S. 2792, National Defense Authorization Act for Fiscal Year 2022, including provisions relating to cybersecurity and incident reporting H.R. 6032 (114th CONGRESS), Data Breach Insurance Act H.R. 6359 (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049 (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224 - Promoting Digital Privacy Technologies Act. S. 2407, Cyber Incident Notification Act of 2021 S. 2491, Defense of United States Infrastructure Act of 2021; provisions relating to Sec. 302, Bureau of Cybersecurity Statistics S. 2875, Cyber Incident Reporting Act of 2021 Monitor H.R. 1996 / S. 910, SAFE Banking Act. Discussions regarding pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity General discussions related to the Driver's Privacy Protection Act
Client expense: $540,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Security Council (NSC), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2021 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2021 · second_quarter · Insurance
H.R. 481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1602 Eliminate Barriers to Innovation Act of 2021 H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 2687 To increase the minimum levels of financial responsibility for transporting property, and to index future increases to changes in inflation relating to medical care H.R. 3138 The State and Local Cybersecurity Improvement Act H.R. 3223 CISA Cyber Exercise Act H.R. 3264 Domains Critical to Homeland Security Act H.R. 3797 (116th CONGRESS), Medical Marijuana Research Act of 2019 H.R. 6032 (114th CONGRESS), Data Breach Insurance Act H.R. 6359 (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049 (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224 - Promoting Digital Privacy Technologies Act. Monitor efforts to examine pandemic insurance; monitor H.R. 1996 / S. 910, SAFE Banking Act. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption. Monitor and participate in discussions regarding data privacy and data breach proposals. General discussion around development of an objective measure of marijuana impairment. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020; and H.R. 6497, The Never Again Small Business Protection Act of 2020. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning General discussions related to Executive Order 14028, Improving the Nation's Cybersecurity
Client expense: $290,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Security Council (NSC), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2021 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2021 · first_quarter · Insurance
H.R.481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 3797 (116th CONGRESS), Medical Marijuana Research Act of 2019. H.R. 6359 (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049 (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224 - Promoting Digital Privacy Technologies Act. Monitor efforts to examine pandemic insurance; monitor H.R. 1996 / S. 910, SAFE Banking Act. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption. Discussions regarding data privacy and data breach. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020; and H.R. 6497, The Never Again Small Business Protection Act of 2020. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning.
Client expense: $630,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2021 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2021 · first_quarter · Insurance
H.R.481, Flood Resiliency and Taxpayer Savings Act of 2021. H.R. 1816, To require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes H.R. 3797 (116th CONGRESS), Medical Marijuana Research Act of 2019. H.R. 6359 (116th CONGRESS), Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act. H.R. 6395/S. 4049 (116th CONGRESS), National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity S. 224 - Promoting Digital Privacy Technologies Act. Monitor efforts to examine pandemic insurance; monitor H.R. 1996 / S. 910, SAFE Banking Act. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption. Discussions regarding data privacy and data breach. General discussions about liability exposures and the COVID-19 pandemic. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. General discussions related to international capital standards. Discussions regarding autonomous vehicles. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long-term resilience. Consumer Protection Act, specifically, provisions on risk, insurance. Oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020; and H.R. 6497, The Never Again Small Business Protection Act of 2020. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. Discussions regarding the Cyberspace Solarium Commission Report. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996. General discussions related to OFAC advisory related to ransomware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC). General discussions related to artificial intelligence (AI) and machine learning.
Client expense: $420,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2021 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.
Client expense: $10,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2020 · fourth_quarter · Transportation
HR 1475 Safe to Drive Act - support efforts to increase grant funding to states to reduce distracted driving HR 3888 The Impaired Driving Study Act of 2019 and HR 3890 The Combating Impaired Driving Act of 2019 support increased study and awareness of the dangers of drug impaired driving; HR 3797, HR 4322 and S 2400 Expanding Cannabis Research and Information Act - monitoring these bills which would allow for federal research into cannabis topics, especially the impact of cannabis use on driving. HR 3593 - The Hot Cars Act - support this bill to require new vehicles to be equipped with a child alert system. HR 2 The Moving Forward Act - support provisions in this bill designed to enhance highway safety including crash avoidance technology on new cars and detection/alert systems to prevent hot car deaths HR 7095 The Invest in America Act - support provisions in this bill designed to improve highway safety including measures to reduce distracted driving HR 4354 HALT Drunk Driving Act; support S 2605 Reduce Impaired Driving for Everyone Act; support S 4123 Stay Aware for Everyone Act of 2020; monitoring this bill which could encourage technology to monitor driver behavior HR 8350 The SELF Drive Act - monitor this bill dealing with regulation of highly automated vehicles
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion
Client expense: $1,650,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · first_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion
Client expense: $1,710,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Insurance
H.R. 2, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act HR 133 - The Consolidated Appropriations Act of 2021 H.R. 1418, the Competitive Health Insurance Reform Act of 2020. H.R. 1595, SAFE Banking Act to include amendments related to insurance H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1668, IoT Cybersecurity Improvement Act of 2020 H.R. 2013, Information Transparency & Personal Data Control Act H.R. 4978, Online Privacy Act of 2019 H.R. 3797, Medical Marijuana Research Act of 2019 H.R. 4074/S. 2201, Clarifying Law Around Insurance of Marijuana (CLAIM) Act H.R. 5265/S. 2621, Holocaust Insurance Accountability Act of 2019 H.R. 6359, Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, including provisions relating to insurance H.R. 8048, State and Local IT Modernization and Cybersecurity Act S. 734, Internet of Things Cybersecurity Improvement Act of 2019 S. 1762, Foreign Agents Disclosure and Registration Enhancement Act of 2019 S. 1790, National Defense Authorization Act for Fiscal Year 2020, including provisions relating to cyber security S. 2968, Consumer Online Privacy Rights Act S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 S. 3456, Consumer Data Privacy and Security Act of 2020 S. 4051, Lawful Access to Encrypted Data Act S. 4626, A bill to establish data privacy and data security protections for consumers in the United States S. 5020, A bill to repeal section 230 of the Communications Act of 1934. Implementation of Public Law No. 111-203, Dodd-Frank Wall Street Reform and Consumer Protection Act, specifically, provisions on risk, insurance oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. Implementation of the Terrorism Risk Insurance Program Reauthorization Act P.L. 116-94. Monitor efforts to examine pandemic insurance, including H.R. 7011, the Pandemic Risk Insurance Act of 2020; H.R. 6494, the Business Interruption Insurance Coverage Act of 2020; and H.R. 6497, The Never Again Small Business Protection Act of 2020. Discussions regarding the Cyberspace Solarium Commission Report Discussions on U.S. and global designation of systemically relevant non-bank financial firms. Discussions regarding data privacy. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Insurance Capital Investment. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long term resilience. Military Lending Act, provisions related to the sale of GAP and credit insurance to service members. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. Discussions regarding autonomous vehicles. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions related to establishment of voluntary cybersecurity insurance certifications. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions. General discussions related to an executive order on promoting the use of trustworthy artificial intelligence in the federal government. General discussions related to Section 230 of the Communications Decency Act (CDA) of 1996 General discussions related to OFAC advisory related to ransomeware payments. General discussions related to cybersecurity assessment frameworks from DOD (NIST sp 800-171 and CMMC).
Client expense: $390,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2020 · fourth_quarter · Agriculture
Monitored regulations on hemp/CBD issues. Discussions relating to regulation of the CBD industry. Monitored discussions regarding H.R. 3797 Medical Marijuana Research Act. Monitored discussions regarding H.R. 3884 MORE Act of 2020. Monitored discussions regarding S. 2032 Cannabidiol and Marihuana Research Expansion Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2020 · fourth_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion H.R. 2466 State Opioid Response Grants Program Extension H.R. 4974 Substance Use Disorders Training Requirement H.R. 8129 Drug Impaired Driving Education Grant Program
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Health Issues
Extension of threshold for medical expense deduction H.R.3797- Medical Marijuana Research Act S.2032- Cannabidiol and Marihuana Research Expansion Act H.R. 7663- Protecting Access to Post-COVID-19 Telehealth Act of 2020 H.R.7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Expand eligibility for paid family and medical leave for high-risk individuals during the pandemic Telehealth guidelines for making the flexibilities permanent Medicaid non-emergency medical transportation (NEMT) Improving Seniors Timely Access to Care Act (H.R. 3107) S. 1384, the Prescription Drug Rebate Reform Act of 2019 S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 H.R. 601 - Medical Cannabis Research Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid Coronavirus Aid, Relief, and Economic Security Act General information about Parkinson's disease, the need for research funding, and protecting access to care
Client expense: $18,500 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · fourth_quarter · Health Issues
Issues related to the Food and Drug Administration. Issues related to the COVID-19 pandemic. Issues related to the cannabis research: S.2032: Cannabidiol and Marihuana Research Expansion Act. H.R.3797: Medical Marijuana Research Act. H.R.7614: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021. H.R.3884: MORE Act of 2020. H.R.133 [116TH]: Consolidated Appropriations Act, 2021.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
S. 1028; H.R. 2093 - STATES Act S. 597; H.R. 1456 - Marijuana Justice Act S. 1552; H.R. 2843 - Marijuana Freedom and Opportunity Act H. Res. 163 - RESPECT Resolution S. 420; H.R. 1120 - Marijuana Revenue and Regulations Act H.R. 3884, S. 2227 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 Appropriations amendments related to state (including the District of Columbia) cannabis laws H.R.3797 - Medical Marijuana Research Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids, including H.R. 3797, The Medical Marijuana Research Act of 2019.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Alcohol and Drug Abuse
H.R. 2466: State Opioid Response Grant Authorization Act H.R. 2922: Respond Now Act H.R. 3496, S. 1983: Create Opportunities Act H.R. 2569, S. 1365: Comprehensive Addiction Resources Emergency Act H.R. 3797, Medical Marijuana Research Act S.2032, Cannabidiol and Marihuana Research Expansion Act Re-Authorize Residential Substance Abuse Treatment Act of 2020(Discussion draft, no bill number) S. 5000: CARA 2.0
Client expense: $216,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
2020 · fourth_quarter · Transportation
HR 1475 Safe to Drive Act - support efforts to increase grant funding to states to reduce distracted driving HR 3888 The Impaired Driving Study Act of 2019 and HR 3890 The Combating Impaired Driving Act of 2019 support increased study and awareness of the dangers of drug impaired driving; HR 3797, HR 4322 and S 2400 Expanding Cannabis Research and Information Act - monitoring these bills which would allow for federal research into cannabis topics, especially the impact of cannabis use on driving. HR 3593 - The Hot Cars Act - support this bill to require new vehicles to be equipped with a child alert system. HR 2 The Moving Forward Act - support provisions in this bill designed to enhance highway safety including crash avoidance technology on new cars and detection/alert systems to prevent hot car deaths HR 7095 The Invest in America Act - support provisions in this bill designed to improve highway safety including measures to reduce distracted driving HR 4354 HALT Drunk Driving Act; support S 2605 Reduce Impaired Driving for Everyone Act; support S 4123 Stay Aware for Everyone Act of 2020; monitoring this bill which could encourage technology to monitor driver behavior HR 8350 The SELF Drive Act - monitor this bill dealing with regulation of highly automated vehicles
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Provisions relating to NIH, substance use research Barriers to research resulting from DEA scheduling, Drug research related issues S. 2032, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues H.R.3797, Medical Marijuana Research Act of 2019, Drug abuse research related issues Monitor Drug abuse research related issues, as follows: Stop the Importation and Trafficking of Synthetic Analogues (SITSA) S.3148, Stopping Overdoses of Fentanyl Analogues Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act Non Human Primates and Biomedical research
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · fourth_quarter · Alcohol and Drug Abuse
H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) H.R.8732 - To modify reporting requirements under the Controlled Substances Act (Kathy Castor, D-FL-14)
Client expense: $470,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana
Client expense: $20,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2020 · third_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion H.R. 2466 State Opioid Response Grants Program Extension H.R. 4974 Substance Use Disorders Training Requirement H.R. 8129 Drug Impaired Driving Education Grant Program
Client expense: $1,570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · third_quarter · Insurance
H.R. 2, Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act H.R. 1595, SAFE Banking Act to include amendments related to insurance H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1668, IoT Cybersecurity Improvement Act of 2020 H.R. 2013, Information Transparency & Personal Data Control Act H.R. 4978, Online Privacy Act of 2019 H.R. 3797, Medical Marijuana Research Act of 2019 H.R. 4074/S. 2201, Clarifying Law Around Insurance of Marijuana (CLAIM) Act H.R. 5265/S. 2621, Holocaust Insurance Accountability Act of 2019 H.R. 6359, Promoting Infrastructure by Protecting Our Subcontractors and Taxpayers Act H.R. 6395/S. 4049, National Defense Authorization Act for Fiscal Year 2021, including provisions relating to cybersecurity H.R. 7011, Pandemic Risk Insurance Act of 2020 H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, including provisions relating to insurance H.R. 8048, State and Local IT Modernization and Cybersecurity Act S. 734, Internet of Things Cybersecurity Improvement Act of 2019 S. 1790, National Defense Authorization Act for Fiscal Year 2020, including provisions relating to cyber security S. 2968, Consumer Online Privacy Rights Act S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 S. 3456, Consumer Data Privacy and Security Act of 2020 S. 4051, Lawful Access to Encrypted Data Act S. 4626, A bill to establish data privacy and data security protections for consumers in the United States Implementation of Public Law No. 111-203, Dodd-Frank Wall Street Reform and Consumer Protection Act, specifically, provisions on risk, insurance oversight (Federal Insurance Office), and potential CFPB activities related to P&C insurance. Implementation of the Terrorism Risk Insurance Program Reauthorization Act P.L. 116-94. Discussions regarding the Cyberspace Solarium Commission Report Discussions on U.S. and global designation of systemically relevant non-bank financial firms. Discussions regarding data privacy. General discussions about liability exposures and the COVID-19 pandemic. General discussions on Insurance Capital Investment. General discussions on Commercial Insurance regulation. General issues related to resilience and mitigation, as related to P&C insurance. Legislation and proposals regarding natural catastrophe related policies. Discussions regarding the insurability of cyber exposures. Legislation and proposals related to the national Flood Insurance Program focused on pre-event mitigation and long term resilience. Military Lending Act, provisions related to the sale of GAP and credit insurance to service members. General discussions related to the Federal Insurance Office. General discussions related to international capital standards. Discussions regarding autonomous vehicles. General discussions on global insurers in the marketplace. General discussions on the International Association of Insurance Supervisors. General discussions on innovation in the insurance industry. General discussions on retroactive active changes to business interruption insurance. General discussions on flood resilience and the U.S. mortgage market. General discussions related to establishment of voluntary cybersecurity insurance certifications. General discussions on relating to supply chain resiliency vis-a-vis the COVID-19 pandemic and other disruptions.
Client expense: $460,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Risk Management Agency, SENATE, State, Dept of (DOS), Treasury, Dept of
2020 · third_quarter · Health Issues
Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids, including H.R. 3797, The Medical Marijuana Research Act of 2019.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Transportation
HR 1475 Safe to Drive Act - support efforts to increase grant funding to states to reduce distracted driving HR 3888 The Impaired Driving Study Act of 2019 and HR 3890 The Combating Impaired Driving Act of 2019 support increased study and awareness of the dangers of drug impaired driving; HR 3797, HR 4322 and S 2400 Expanding Cannabis Research and Information Act - monitoring these bills which would allow for federal research into cannabis topics, especially the impact of cannabis use on driving. HR 3593 - The Hot Cars Act - support this bill to require new vehicles to be equipped with a child alert system. HR 2 The Moving Forward Act - support provisions in this bill designed to enhance highway safety including crash avoidance technology on new cars and detection/alert systems to prevent hot car deaths HR 7095 The Invest in America Act - support provisions in this bill designed to improve highway safety including measures to reduce distracted driving HR 4354 HALT Drunk Driving Act; support S 2605 Reduce Impaired Driving for Everyone Act; support S 4123 Stay Aware for Everyone Act of 2020; monitoring this bill which could encourage technology to monitor driver behavior HR 8350 The SELF Drive Act - monitor this bill dealing with regulation of highly automated vehicles
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Barriers to research resulting from DEA scheduling, Drug research related issues S. 2032, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues H.R.3797, Medical Marijuana Research Act of 2019, Drug abuse research related issues Monitor Drug abuse research related issues, as follows: Stop the Importation and Trafficking of Synthetic Analogues (SITSA) S.3148, Stopping Overdoses of Fentanyl Analogues Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act Coronavirus, Healthcare research related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · third_quarter · Alcohol and Drug Abuse
H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) , ALL PROVISIONS H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) , ALL PROVISIONS S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) , ALL PROVISIONS H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) , ALL PROVISIONS H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) , ALL PROVISIONS oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) , ALL PROVISIONS H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) , ALL PROVISIONS H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) , ALL PROVISIONS S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) , ALL PROVISIONS S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA) , ALL PROVISIONS S.4386 - A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes (Tina Smith, D-MN) , ALL PROVISIONS H.R.8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (Kurt Schrader, D-OR-5) , ALL PROVISIONS
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana
Client expense: $20,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2020 · second_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion
Client expense: $2,090,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · second_quarter · Alcohol and Drug Abuse
H.R. 1595 - SAFE Banking Act of 2019 (Ed Perlmutter, D-CO-7) H.R.1119 - To amend the Controlled Substances Act to reduce the gap between Federal and State marijuana policy, and for other purposes (Earl Blumenauer, D-OR-3) H.R.2012 - To amend the Controlled Substances Act to provide that Federal law shall not preempt State law (Diana DeGette, D-CO-1) S.2400 - A bill to promote cannabis research, and for other purposes (Dick Durbin, D-IL) H.R.3884 - Marijuana Opportunity Reinvestment and Expungement Act of 2019 (Jerrold Nadler, D-NY-10) H.R.3884 - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes (Jerrold Nadler, D-NY-10) oSenate version introduced by Kamala Harris, S.2227 H.R.3797 - To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes (Earl Blumenauer, D-OR-3) H.R.4322 - Expanding Cannabis Research and Information Act (Donna Shalala, D-FL-27) H.R.4323 - Marijuana 1-to-3 Act of 2019 - To provide for the rescheduling of marijuana into schedule III of the Controlled Substances Act (Gregory Steube, R-FL-17) S.2979 - A bill to improve drug testing for transportation-related activities (Roger Wicker, R-MS) S.3070 - A bill to modify reporting requirements under the Controlled Substances Act (Dianne Feinstein, D-CA)
Client expense: $550,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Drug abuse research related issues, as follows: Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Barriers to research resulting from DEA scheduling S.3148, Stopping Overdoses of Fentanyl Analogues Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act Monitor Drug abuse research related issues, as follows: S. 2032, Cannabidiol & Marijuana Research Expansion Act H.R.3797, Medical Marijuana Research Act of 2019 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act Coronavirus, Healthcare research related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana
Client expense: $30,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2020 · second_quarter · Transportation
HR 1475 Safe to Drive Act - support efforts to increase grant funding to states to reduce distracted driving HR 3888 The Impaired Driving Study Act of 2019 and HR 3890 The Combating Impaired Driving Act of 2019 support increased study and awareness of the dangers of drug impaired driving; HR 3797, HR 4322 and S 2400 Expanding Cannabis Research and Information Act - monitoring these bills which would allow for federal research into cannabis topics, especially the impact of cannabis use on driving. HR 3593 - The Hot Cars Act - support this bill to require new vehicles to be equipped with a child alert system. HR 2 The Moving Forward Act - support provisions in this bill designed to enhance highway safety including crash avoidance technology on new cars and detection/alert systems to prevent hot car deaths HR 7095 The Invest in America Act - support provisions in this bill designed to improve highway safety including measures to reduce distracted driving
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · first_quarter · Alcohol and Drug Abuse
H.R. 2012 Controlled Substances Federal Law Preemption H.R. 2070 Law Enforcement Chemical Screening Devices H.R. 2093 Marijuana Controlled Substances Application H.R. 2843 Marijuana Decriminalization H.R. 3159 Drugged Driving Prevention Pilot Program S. 1028 Marijuana Controlled Substances Application S. 1552 Marijuana Decriminalization H.R. 3797 Medical Marijuana Research Access H.R. 4322 Cannabis Research Promotion H.R. 4323 Marijuana Controlled Substances Rescheduling S. 2400 Cannabis Research Promotion
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana
Client expense: $40,000 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), White House Office
2020 · first_quarter · Health Issues
HR 171; HR 601; HR 3797; HR2843; HR 3884, S2032 - Marijuana Research Bills
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Drug abuse research related issues, as follows: S. 2032, Cannabidiol & Marijuana Research Expansion Act Stop the Importation and Trafficking of Synthetic Analogues (SITSA) H.R.3797, Medical Marijuana Research Act of 2019 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Barriers to research resulting from DEA scheduling Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.3148, Stopping Overdoses of Fentanyl Analogues Act Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Monitor Coronavirus, Healthcare related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE